major
focu
system
biolog
character
interact
cellular
compon
order
develop
accur
pictur
intric
network
within
biolog
system
past
decad
protein
microarray
greatli
contribut
advanc
proteom
becom
import
platform
system
biolog
protein
microarray
highli
flexibl
rang
largescal
proteom
microarray
smaller
customiz
microarray
make
technolog
amen
detect
broad
spectrum
biochem
properti
protein
articl
focu
numer
studi
util
protein
microarray
reconstruct
biolog
network
includ
proteindna
interact
posttransl
protein
modif
ptm
lectinglycan
recognit
pathogenhost
interact
hierarch
signal
cascad
divers
applic
allow
integr
interact
data
numer
molecular
class
cellular
state
provid
insight
structur
complex
biolog
system
also
discuss
emerg
applic
futur
direct
protein
microarray
technolog
global
frontier
sinc
complet
major
whole
genom
sequenc
effort
scientif
commun
face
challeng
identifi
character
express
gene
product
given
organ
postgenom
era
gave
birth
field
proteom
aim
systemat
chart
biochem
properti
function
express
protein
global
view
mind
strive
integr
complex
omic
data
molecular
rank
scope
proteom
limit
identifi
proteinprotein
interact
also
includ
identif
protein
posttransl
modif
ptm
interact
dna
rna
sequenc
lipid
glycan
weav
layer
togeth
allow
us
construct
care
tune
network
exist
within
live
cell
improv
high
throughput
proteom
technolog
coupl
advanc
genom
bioinformat
laid
framework
enabl
level
research
two
power
platform
proteom
studi
mass
spectrometri
protein
microarray
technolog
although
mass
spectrometri
well
suit
high
throughput
protein
identif
quantif
ptm
site
map
still
disadvantag
bia
low
abund
protein
modif
well
undersampl
complex
proteom
contrari
protein
microarray
platform
avoid
limit
particularli
suit
unbias
global
profil
protein
microarray
also
term
protein
chip
creat
immobil
thousand
differ
protein
eg
antigen
antibodi
enzym
substrat
etc
discret
spatial
locat
high
densiti
solid
surfac
depend
applic
protein
microarray
categor
two
varieti
analyt
function
protein
microarray
analyt
protein
microarray
usual
compos
wellcharacter
biomolecul
specif
bind
activ
antibodi
analyz
compon
complex
biolog
sampl
eg
serum
cell
lysat
determin
whether
sampl
contain
specif
protein
interest
use
protein
activ
profil
biomark
identif
cell
surfac
markerglycosyl
profil
clinic
diagnosi
environmentalfood
safeti
analysi
altern
function
protein
microarray
construct
print
larg
number
individu
purifi
protein
mainli
use
comprehens
queri
biochem
properti
activ
immobil
protein
principl
feasibl
print
array
compos
virtual
annot
protein
given
organ
effect
compris
wholeproteom
microarray
snyder
group
report
fabric
first
proteom
microarray
bud
yeast
repres
major
advanc
field
order
construct
array
approxim
fulllength
yeast
orf
individu
express
yeast
protein
product
purifi
ntermin
gstfusion
protein
purifi
protein
robot
spot
singl
glass
slide
duplic
high
densiti
form
first
proteom
microarray
cover
yeast
proteom
recent
proteom
microarray
fabric
proteom
virus
bacteria
plant
human
function
protein
microarray
success
appli
identifi
proteinprotein
proteinlipid
proteinantibodi
proteinsmal
molecul
proteindna
proteinrna
proteinlectin
lectincel
interact
identifi
substrat
enzym
phosphoryl
ubiquityl
acetyl
nitrosyl
well
profil
immun
respons
review
focu
invent
applic
protein
microarray
signific
find
contribut
understand
complex
interactom
within
cell
tabl
solid
understand
molecular
mechan
biolog
function
requir
systemat
profil
dynam
interact
biomolecul
process
transcript
regul
viral
infect
numer
ptm
proteinprotein
interact
account
small
fraction
potenti
molecular
interact
within
cell
highlight
fundament
network
essenti
function
high
throughput
technolog
strive
provid
unbias
platform
chart
relationship
proteom
genom
scale
section
review
sever
studi
demonstr
util
protein
microarray
reconstruct
interact
network
complet
human
genom
sequenc
decod
function
element
major
challeng
comput
approach
power
identifi
conserv
dna
regulatori
element
howev
comput
strategi
confid
predict
protein
bind
element
identif
interact
network
dna
function
element
human
proteom
requir
extens
predict
power
high
throughput
techniqu
hu
colleagu
undertook
largescal
analysi
proteindna
interact
pdi
use
protein
microarray
compos
uniqu
full
length
human
protein
encompass
annot
transcript
factor
tf
member
mani
protein
categori
rnabind
protein
chromatinassoci
protein
nucleotidebind
protein
transcript
coregul
mitochondri
protein
protein
kinas
protein
microarray
probe
predict
known
dna
motif
result
total
pdi
identifi
mani
known
pdi
larg
number
new
pdi
well
character
predict
tf
recov
well
new
consensu
site
human
tf
surprisingli
protein
encod
known
dnabind
domain
show
sequencespecif
pdi
suggest
mani
human
protein
may
bind
specif
dna
sequenc
secondari
function
investig
whether
dnabind
activ
unconvent
dna
bind
protein
udbp
physiolog
relev
hu
et
al
carri
indepth
analysi
wellstudi
protein
kinas
determin
potenti
mechan
behind
dnabind
activ
use
combin
vitro
vivo
approach
electrophoret
mobil
shift
assay
emsa
luciferas
assay
mutagenesi
chromatin
immunoprecipit
chip
demonstr
dnabind
activ
independ
protein
kinas
activ
act
transcript
repressor
transcript
induc
interferon
gamma
signal
approach
allow
sophist
network
map
proteindna
interact
enabl
discoveri
uncharacter
dnabind
protein
emerg
udbp
strengthen
abil
piec
togeth
machineri
involv
transcript
regul
mitogenactiv
protein
kinas
mapk
signal
cascad
involv
hierarchi
kinas
activ
one
anoth
consecut
phosphoryl
event
respons
extracellular
intracellular
signal
standard
method
abl
establish
combinatori
connect
upstream
mkkactiv
kinas
mkkk
downstream
mpkactiv
kinas
mkk
mapk
cytoplasm
nuclear
substrat
construct
complic
interconnect
network
necessit
systemat
unbias
highthroughput
approach
avoid
confound
issu
redund
function
pleiotropi
akin
protein
microarray
base
kinas
assay
develop
ptacek
et
al
popescu
et
al
employ
highdens
protein
microarray
identifi
novel
mpk
substrat
author
first
determin
arabidopsi
thaliana
mkk
preferenti
activ
differ
mpk
vivo
use
activ
mpk
probe
arabidopsi
protein
microarray
contain
uniqu
protein
reveal
phosphoryl
substrat
initi
screen
identifi
nonredund
mpk
phosphoryl
substrat
averag
target
per
activ
mpk
data
author
abl
reconstruct
complex
signal
cascad
involv
nine
mkk
mpk
substrat
moreov
result
node
edg
highlight
specif
conserv
within
interact
mpk
phosphoryl
target
hit
one
mpk
phosphoryl
two
mpk
gene
ontolog
go
analysi
effector
substrat
show
enrich
tf
involv
regul
develop
defens
stress
respons
network
emerg
studi
suggest
mapk
signal
cascad
regul
transcript
combinatori
enzym
specif
discret
phosphoryl
event
ubiquityl
one
widespread
ptm
mediat
huge
rang
cellular
event
process
eukaryot
understand
ubiquitin
substrat
specif
complex
combinatori
question
confer
uniqu
permut
enzym
lu
et
al
develop
assay
determin
substrat
hect
domain
ligas
use
yeast
proteom
microarray
novel
protein
found
readili
ubiquityl
eight
valid
vivo
target
deeper
vivo
character
two
substrat
reveal
ubiquityl
affect
either
posttransl
process
substrat
subcellular
local
design
offer
abil
dissect
molecular
mechan
complex
enzymat
cascad
give
field
tool
understand
system
organ
global
acetyl
major
epigenet
ptm
wide
known
role
regul
chromatin
state
howev
suspect
regul
nonnuclear
function
well
yeast
nonhiston
protein
report
substrat
histon
acetyltransferas
hat
histon
deacetylas
hdac
catalyt
enzym
essenti
nucleosom
acetyltransferas
complex
essenti
hat
yeast
strongli
suggest
may
mediat
acetyl
nonhiston
protein
critic
cell
surviv
anoth
intrigu
question
whether
hat
could
regul
activ
cytosol
protein
even
enzym
like
protein
kinas
comprehens
discov
nonchromatin
substrat
hat
complex
yeast
proteom
lin
et
al
develop
vitro
acetyl
reaction
yeast
proteom
microarray
contain
yeast
protein
use
c
acetylcoa
nonhiston
protein
readili
acetyl
complex
although
expect
major
substrat
would
involv
nucleosom
assembl
histon
bind
categori
signific
number
identifi
substrat
cytoplasm
protein
metabol
enzym
twenti
protein
involv
varieti
cellular
function
metabol
transcript
cell
cycl
progress
rna
process
stress
respons
select
valid
standard
doubleimmunoprecipit
techniqu
use
valid
substrat
includ
phosphoenolpyruv
carboxykinas
understand
physiolog
relev
nonchromatin
acetyl
author
focus
cytosol
enzym
explor
connect
acetyl
metabol
tandem
mass
spectrometri
msm
identifi
lysin
acetyl
site
sitedirect
mutagenesi
reveal
acetyl
critic
enzymat
activ
promot
exten
live
mammalian
cell
cell
surfac
biomark
identif
sion
life
span
yeast
grow
starvat
condit
find
demonstr
function
role
nonchromatin
acetyl
yeast
metabol
longev
base
go
analysi
acetyl
may
regul
sever
cellular
process
well
follow
studi
lu
et
al
investig
impact
acetyl
anoth
substrat
regulatori
subunit
kinas
complex
yeast
ampk
base
msm
analysi
sitedirect
mutagenesi
studi
author
found
acetyl
enhanc
interact
catalyt
subunit
inhibit
kinas
activ
result
phosphoryl
one
downstream
target
homolog
akt
decreas
ultim
lead
slower
growth
extend
replic
life
span
final
author
demonstr
antiag
effect
acetyl
independ
extrins
nutrient
avail
activ
studi
echo
recent
discoveri
mani
mitochondri
cytosol
enzym
substrat
acetyltransferas
higher
eukaryot
via
msbase
ptm
profil
readili
gener
snapshot
global
protein
ptm
profil
variou
cellular
condit
could
consid
holi
grail
research
ptm
gener
ptm
substrat
identif
strategi
requir
enrich
cell
extract
sampl
follow
ms
vitro
assay
use
purifi
compon
approach
strength
weak
hybrid
two
possibl
use
concentr
mammalian
cell
extract
combin
protein
microarray
serv
identifi
ptm
target
semiin
vivo
set
allevi
challeng
analyz
complex
mixtur
merbl
kirschner
gener
cell
extract
replic
mitot
checkpoint
anaphas
releas
identifi
differenti
regul
polyubiquityl
substrat
synchron
cell
extract
incub
invitrogen
human
protoarray
compos
protein
result
polyubiquityl
protein
detect
antibodi
direct
ubiquitin
chain
author
expect
recov
substrat
anaphas
promot
complex
apc
major
ubiquitin
ligas
mitosi
differenti
polyubiquityl
substrat
apc
ligas
merbl
kirschner
design
three
experiment
set
up
cell
extract
arrest
nocodozol
control
inhibit
apc
second
condit
sampl
releas
checkpoint
arrest
addit
ligas
final
condit
supplement
specif
inhibitor
apc
approxim
protein
differenti
polyubiquityl
known
apc
substrat
confirm
valid
experiment
design
valid
studi
perform
rabbit
reticulocyt
lysat
confirm
degrad
ubiquityl
novel
apc
substrat
studi
demonstr
efficaci
use
protein
microarray
combin
cell
extract
recapitul
global
ptm
signatur
specif
cellular
state
protein
microarray
allow
explor
hypothes
address
standard
method
investig
interact
viral
encod
protein
protein
within
infect
host
import
yet
cumbersom
task
protein
microarray
compos
either
host
viral
proteom
fabric
subsequ
use
examin
relationship
viral
machineri
host
vitro
approach
recapitul
viral
infect
viral
genomeproteom
allow
physic
interact
host
hayward
zhu
group
recent
develop
new
paradigm
examin
direct
interact
viral
host
protein
lead
deeper
understand
mechan
viral
protein
hijack
host
well
uncov
direct
target
major
viral
enzym
human
b
c
herpesvirus
caus
diseas
distinct
one
anoth
rang
mild
cold
sore
pneumon
birth
defect
cancer
although
virus
differ
enter
host
cell
must
reprogram
cellular
gene
express
sens
cellcycl
phase
modifi
cellcycl
progress
reactiv
lytic
life
cycl
produc
new
virion
spread
infect
mani
lytic
cycl
gene
involv
replic
viral
genom
highli
conserv
across
herpesviru
famili
exampl
herpesviru
encod
ortholog
serinethreonin
kinas
share
structur
similar
human
cyclindepend
kinas
cdk
phosphoryl
substrat
cdk
abil
viral
kinas
mimic
host
cdk
result
hijack
key
pathway
potenti
replic
particular
cellular
phosphoryl
event
observ
herp
infect
specif
phosphoryl
antivir
drug
infect
cell
mediat
conserv
viral
kinas
identifi
collect
host
target
viral
kinas
would
reveal
commonli
share
mechan
signal
pathway
among
differ
herpesvirus
promot
lytic
replic
knowledg
increas
therapeut
target
option
necessari
develop
panantivir
test
idea
li
et
al
util
human
transcript
factor
tf
proteom
array
contain
human
protein
identifi
commonli
share
substrat
herpesvirusencod
kinas
parallel
kinas
assay
perform
use
four
viral
kinas
encod
herp
simplex
type
human
cytomegaloviru
hcmv
epsteinbarr
viru
ebv
kaposi
sarcoma
associatedviru
kshv
respect
total
nonredund
substrat
identifi
across
four
kinas
substrat
target
least
three
kinas
go
analysi
share
substrat
indic
dna
damag
function
class
significantli
enrich
among
dna
damag
protein
select
lead
candid
regul
viral
replic
due
role
dna
damag
well
transcript
regul
hat
activ
phosphoryl
ebvinfect
b
cell
valid
analysi
known
phosphoryl
multipl
ebv
protein
small
number
host
protein
function
previouslycharacter
target
vari
impli
kinas
play
multipl
role
promot
viral
replic
express
earli
phase
lytic
infect
cycl
local
mainli
nuclei
ebvinfect
cell
knockdown
reveal
critic
releas
infecti
viru
viral
lytic
reactiv
subsequ
experi
demonstr
phosphoryl
enhanc
hat
activ
link
phosphoryl
event
viral
replic
also
demonstr
import
phosphoryl
host
dna
damag
protein
viral
replic
specif
phosphoryl
activ
trigger
ebvinduc
dna
damag
respons
ddr
promot
posit
transcript
regul
critic
lytic
gene
involv
viral
replic
lastli
studi
confirm
also
requir
effici
lytic
replic
hcmv
kshv
taken
togeth
unbias
approach
provid
novel
paradigm
discoveri
conserv
target
viral
enzym
herp
kinas
credibl
therapeut
candid
know
target
signal
pathway
exploit
better
enabl
develop
wide
effect
antivir
drug
follow
studi
li
et
al
took
invers
approach
employ
herpesviru
ebv
protein
microarray
assess
humanhost
protein
bind
event
small
ubiquitinrel
modifi
sumo
coval
attach
protein
via
enzymat
cascad
analog
ubiquitin
pathway
sumo
involv
broad
rang
cellular
process
includ
signal
transduct
regul
transcript
dna
damag
respons
mediat
proteinprotein
interact
latent
lytic
ebv
protein
interact
compon
sumo
machineri
coval
modif
sumo
commonli
understood
noncoval
interact
sumo
also
contribut
sumo
effector
signal
noncoval
bind
sumo
often
mediat
sumointeract
motif
sim
domain
target
protein
comprehens
identifi
ebv
protein
bind
sumo
moieti
author
fabric
protein
microarray
full
length
protein
ebv
kshv
individu
purifi
yeast
array
use
perform
proteinprotein
bind
assay
use
paralog
identifi
ebv
protein
potenti
sumo
partner
includ
conserv
kinas
known
play
multitud
role
ebv
author
pursu
import
cellular
ptm
function
sim
domain
map
mutat
nand
ctermin
sim
intracellular
local
kinas
shift
nuclear
cytoplasm
mutat
ntermin
sim
show
larg
nuclear
local
wherea
ctermin
sim
mutat
gener
intermedi
phenotyp
nuclear
cytoplasm
express
author
found
inhibit
sumoyl
lytic
cycl
transactiv
zta
demonstr
sim
domain
well
kinas
activ
requir
inhibit
sim
domain
also
shown
necessari
suppress
global
sumoyl
induc
cellular
ddr
promot
ebv
lytic
replic
viru
take
advantag
sumoyl
system
encod
protein
sumo
modifi
bind
sumo
previous
mention
sumo
involv
ddr
support
find
appear
interact
site
dna
damag
via
sumo
bind
reveal
addit
mechan
promot
ebvmedi
ddr
lytic
replic
sumo
interact
import
kinas
activ
function
anoth
variat
protein
microarray
use
investig
pathogenhost
interact
involv
human
tf
array
profil
interact
kshv
latenc
protein
host
protein
kshvassoci
malign
major
tumor
cell
latentlyinfect
express
viral
latenc
protein
includ
lana
lana
function
maintain
kshv
latenc
drive
viral
replic
promot
dysregul
cell
growth
dynam
regul
viral
cell
gene
transcript
identif
lana
interact
partner
would
provid
new
insight
mechan
lana
use
maintain
latent
infect
lana
attract
target
previou
effort
identifi
lana
bind
protein
attempt
yeast
twohybrid
screen
glutathion
stransferas
gst
affin
immunoprecipit
ms
result
appar
approachdepend
bind
partner
recent
studi
shamay
et
al
purifi
flagtag
lana
probe
human
tf
array
recov
candid
bind
partner
eight
candid
valid
coimmunoprecipit
assay
includ
protein
phosphatas
replic
protein
rpa
xpa
lanaassoci
retain
acetyltransferas
activ
show
enhanc
stabil
consist
li
et
al
find
critic
kshv
lytic
replic
see
bind
interact
lana
rpa
xpa
seem
echo
lana
role
dna
damag
character
lana
abil
bind
addit
rpa
complex
member
spawn
new
hypothesi
lana
may
also
regul
host
telomer
length
test
hypothesi
author
perform
chip
assay
antibodi
use
primer
specif
telomer
region
found
presenc
lana
drastic
reduc
recruit
host
telomer
impact
protein
level
rpa
complex
observ
rais
possibl
lana
might
affect
telomer
length
use
southern
blot
analysi
termin
restrict
fragment
standard
method
quantifi
telomer
length
author
demonstr
averag
length
telomer
shorten
least
lanaexpress
endotheli
cell
kshvinfect
primari
effus
lymphoma
cell
biomark
identif
repres
major
effort
modern
biomed
clinic
research
allow
better
screen
method
diagnosi
criteria
prognosi
predict
ultim
superior
treatment
broad
rang
diseas
tradit
biomark
discoveri
util
popular
method
ms
elisa
gene
express
antibodi
array
profil
serum
sampl
recent
year
protein
microarray
technolog
extend
clinic
proteom
becom
power
tool
biomark
discoveri
protein
function
protein
microarray
origin
view
substrat
bind
partner
appli
immunolog
protein
array
could
potenti
antigen
associ
certain
diseas
comparison
protein
microarray
basedserum
profil
much
sensit
perform
higher
throughput
requir
less
amount
sampl
review
varieti
clinicallyrelev
applic
protein
microarray
biomark
identif
mani
autoimmun
diseas
unmet
clinic
need
costeffect
accur
diagnost
method
improv
upon
current
standard
requir
discoveri
character
reliabl
autoantigen
coupl
sensit
reproduc
assay
take
autoimmun
hepat
aih
exampl
aih
chronic
necroinflammatori
diseas
human
liver
littl
known
etiolog
detect
nonorganspecif
liverrel
autoantibodi
use
immunoserolog
approach
wide
use
diagnosi
prognosi
howev
tradit
autoantigen
antismooth
muscl
autoantibodi
sma
antiantinuclear
autoantibodi
ana
often
mixtur
complex
biolog
materi
unambigu
accur
detect
diseas
demand
identif
character
autoantigen
therefor
song
et
al
fabric
human
protein
microarray
nonredund
protein
express
purifi
gst
fusion
yeast
sever
advantag
associ
produc
human
protein
yeast
rather
bacteria
higher
solubl
higher
yield
larg
protein
eg
kd
better
preserv
conform
protein
less
immunogen
protein
produc
yeast
escherichia
coli
howev
unlik
viral
bacteri
protein
microarray
signific
obstacl
use
human
protein
microarray
high
content
high
cost
exampl
cost
human
protein
array
protein
exceed
per
array
order
reduc
cost
song
et
al
develop
twophas
strategi
identifi
new
biomark
aih
phase
design
rapid
select
candid
biomark
valid
phase
ii
figur
phase
serum
sampl
aih
patient
healthi
control
select
individu
use
probe
human
protein
microarray
dilut
follow
detect
bound
human
autoantibodi
use
antihuman
igg
antibodi
statist
analysi
reveal
candid
autoantigen
valid
candid
avoid
potenti
overfit
problem
see
especi
like
deal
small
sampl
size
protein
posit
control
repurifi
build
larg
number
lowcost
small
array
phase
ii
valid
array
sequenti
probe
serum
sampl
use
phase
serum
sampl
obtain
addit
aih
primari
biliari
cirrhosi
pbc
hepat
b
viru
hbv
hepat
c
viru
hcv
system
lupu
erythematosu
sle
primari
syndrom
pss
patient
neg
control
also
includ
serum
sampl
patient
suffer
type
sever
diseas
sampl
healthi
subject
three
new
antigen
dutpas
identifi
highli
aihspecif
biomark
sensit
respect
valid
addit
aih
sampl
doubleblind
design
final
demonstr
new
biomark
could
readili
appli
elisabas
assay
clinic
diagnosi
prognosi
figur
scheme
twophas
strategi
biomark
identif
human
autoimmun
diseas
take
aih
exampl
phase
small
cohort
use
rapidli
identifi
group
candid
biomark
via
serum
profil
assay
human
protein
microarray
high
cost
small
number
microarray
need
cost
experi
rel
low
phase
ii
focus
protein
microarray
low
cost
fabric
spot
purifi
candid
protein
much
larger
cohort
assay
array
doubl
blind
fashion
valid
candid
identifi
phase
aih
autoimmun
hepat
asialoglycoprotein
receptor
pbc
primari
biliari
cirrhosi
hbv
hepat
viru
b
hcv
hepat
c
viru
sle
system
lupu
erythematosu
pss
primari
syndrom
studi
repres
new
paradigm
biomark
identif
use
protein
microarray
three
reason
first
manag
number
candid
biomark
rapidli
identifi
low
cost
fewer
expens
protein
microarray
highcont
need
first
phase
twophas
strategi
second
use
small
array
compris
select
candid
protein
valid
step
rapidli
carri
much
larger
cohort
low
cost
valid
step
extrem
import
avoid
overfit
problem
associ
statist
analysi
biomark
classifi
identif
especi
deal
small
cohort
eg
overfit
problem
statist
model
describ
random
error
nois
instead
underli
relationship
gener
occur
biomark
identif
system
excess
complex
mani
individualtoindividu
variat
rel
number
sampl
use
result
biomark
overfit
gener
poor
predict
perform
therefor
test
addit
larger
cohort
doubleblind
design
effect
way
rule
overfit
biomark
third
author
develop
elisabas
assay
examin
perform
valid
biomark
addit
sampl
newli
identifi
biomark
could
serv
translat
step
toward
clinic
practic
protein
microarray
also
use
diagnost
tool
infecti
diseas
sever
acut
respiratori
syndrom
sar
infecti
diseas
caus
novel
coronaviru
cov
appear
guangdong
china
novemb
march
viru
spread
global
juli
sar
case
approxim
death
report
worldwid
time
outbreak
effect
treatment
sar
avail
thu
isol
infect
control
best
way
limit
spread
viru
therefor
rapid
reliabl
earli
diagnosi
critic
control
epidem
zhu
et
al
develop
first
viru
protein
microarray
includ
sarscov
protein
well
protein
five
addit
coronavirus
infect
human
cow
bcv
cat
fipv
mous
sar
microarray
use
screen
sera
infect
noninfect
individu
doubleblind
format
sampl
quickli
distinguish
sar
posit
sar
neg
base
presenc
human
igg
igm
antibodi
sarscov
protein
accuraci
rate
compar
standard
elisa
diagnost
test
sar
microarray
improv
sensit
assay
elisa
dramat
reduc
amount
sampl
requir
method
may
suitabl
diagnosi
mani
viral
infect
two
common
subtyp
inflammatori
bowel
diseas
ibd
crohn
diseas
cd
ulcer
coliti
uc
idiopath
natur
character
abnorm
immunolog
respons
gut
ibd
clinic
thought
autoimmun
etiolog
although
antimicrobi
antibodi
normal
bacteria
present
sera
patient
lead
pathogenesi
diseas
known
serolog
antibodi
current
use
partial
diagnost
criteria
robust
enough
stand
alon
chen
et
al
elect
use
e
coli
proteom
microarray
character
differenti
immun
respons
serum
anti
coli
antibodi
patient
cd
uc
compar
healthi
control
hc
microarray
includ
e
coli
protein
encompass
vast
major
proteom
e
coli
strain
sera
hc
n
cd
n
uc
n
profil
use
array
reactiv
anti
coli
antibodi
detect
antihuman
igg
antibodi
data
analysi
reveal
differenti
immunogen
respons
protein
three
group
highli
immunogen
hc
cd
uc
respect
two
robust
set
novel
serolog
biomark
identifi
discrimin
cd
hc
uc
overal
accuraci
sensit
first
studi
identifi
serolog
biomark
human
immunolog
diseas
respect
entir
proteom
microbi
speci
underli
molecular
patholog
immun
system
relat
diseas
also
examin
proteom
microarray
approach
cell
surfac
glycosyl
complex
highlyvari
ptm
turn
amen
standard
highthroughput
techniqu
glycosyl
present
surfac
vertebr
cell
serv
distinguish
cell
type
delic
differ
also
shown
associ
cell
differenti
malign
transform
subcellular
local
glycan
bind
protein
known
lectin
use
character
glycosyl
mark
due
abil
discrimin
sugar
isoform
lectin
microarray
alreadi
employ
character
glycoprotein
lysat
howev
use
systemat
profil
cell
surfac
glycosyl
signatur
mammalian
cell
type
studi
potenti
provid
tool
distinguish
normal
versu
abnorm
cell
surfac
profil
base
glycanlectin
interact
tao
et
al
fabric
lectin
microarray
compos
nonredund
lectin
select
defin
cell
surfac
glycan
signatur
use
wellstudi
mammalian
cell
line
author
develop
systemat
binari
analysi
bind
interact
select
lectin
cell
type
observ
broad
rang
bind
potenti
specif
across
cell
type
impli
high
level
variat
cell
surfac
glycan
within
mammalian
cell
type
exampl
less
lectin
could
captur
hesc
cell
lectin
captur
cell
interestingli
similar
cell
type
variou
breast
cancer
cell
line
reveal
overlap
lectin
bind
profil
indic
lectin
discern
subtl
differ
physiologicallyrel
cell
test
util
lectin
microarray
biomark
discoveri
tao
et
al
analyz
lectin
bind
model
cancer
stemlik
system
compar
cell
surfac
glycan
signatur
cell
type
focus
breast
cancer
cell
line
adopt
cancer
stemlik
phenotyp
grown
specif
condit
author
demonstr
differ
growth
condit
give
rise
distinct
lectin
bind
profil
distinguish
cancer
cell
subpopul
lectin
lel
identifi
biomark
discrimin
subpopul
author
propos
combin
stem
cell
enrich
method
lectin
microarray
technolog
potenti
tool
identifi
cell
surfac
marker
tumor
enabl
discoveri
cancer
stem
celllik
target
therapi
past
decad
protein
microarray
evolv
power
versatil
tool
system
biolog
capit
femtomolar
sensit
profil
full
proteom
highthroughput
yet
straightforward
assay
describ
util
myriad
applic
result
impact
scientif
find
includ
pathogenhost
interact
biomark
identif
unconvent
transcript
factor
ptm
substrat
figur
protein
microarray
leverag
advantag
uniform
protein
express
proteom
impact
limit
extent
coverag
remark
advanc
put
forth
zhu
laboratori
construct
first
human
proteom
microarray
contain
full
length
protein
largest
avail
date
figur
discoveri
potenti
technolog
dramat
increas
expand
proteom
coverag
multipl
largescal
studi
intend
link
ptm
substrat
upstream
enzym
kinas
sumo
ligas
ubiquitin
ligas
ongo
human
proteom
microarray
number
bona
fide
ptm
increas
substrat
found
acquir
numer
modif
ignor
coregul
ptm
direct
studi
recapitul
crosstalk
enzym
ptm
common
substrat
possibl
protein
microarray
may
uncov
key
node
regul
critic
point
pathway
converg
ms
ideal
technolog
discoveri
novel
ptm
crotonyl
ptm
well
suit
identifi
enzym
respons
novel
modif
rich
nativelypurifi
protein
singl
surfac
provid
ideal
platform
discoveri
novel
enzym
function
human
proteom
array
also
har
tool
highthroughput
character
monoclon
antibodi
mab
specif
hybridoma
capabl
microarray
technolog
expand
develop
labelfre
optic
tech
figur
reconstitut
interact
network
cellular
system
gener
protein
microarray
studi
interact
map
protein
microarray
appli
numer
organ
achiev
divers
represent
molecular
network
li
et
al
probe
human
transcript
factor
tf
microarray
four
conserv
kinas
encod
herpesvirus
reveal
host
target
viral
kinas
verifi
interact
viral
target
host
protein
shown
b
use
yeast
proteom
microarray
lu
et
al
identifi
substrat
hect
ligas
gene
ontolog
analysi
link
subgroup
substrat
base
function
c
thaliana
map
kinas
signal
network
reconstruct
use
arabidopsi
protein
microarray
adapt
permiss
dr
savithramma
p
dineshkumar
hierarch
phosphoryl
network
depict
mkk
upper
node
mpk
middl
node
substrat
bottom
node
dna
bind
specif
unconvent
dnabind
protein
udbp
character
use
tf
microarray
udbp
cluster
base
target
sequenc
similar
protein
differ
function
class
colorcod
c
denot
consensu
sequenc
subbranch
shown
e
e
coli
proteom
microarray
use
identifi
differenti
immunogen
protein
hc
cd
patient
sampl
depict
heat
map
yellow
blue
color
indic
high
low
immunogen
respons
respect
hc
healthi
control
cd
crohn
diseas
niqu
monitor
realtim
dynam
biomolecular
interact
obliqueincid
reflect
differ
oird
emerg
techniqu
measur
chang
reflect
polar
light
oird
recent
appli
dna
protein
microarray
success
determin
associ
dissoci
rate
biomolecular
interact
highthroughput
format
construct
complex
interact
network
involv
full
rang
cellular
compon
critic
deciph
organ
organ
essenti
understand
aberr
chang
result
diseas
discuss
vast
applic
protein
microarray
global
character
interactom
signific
find
creat
comprehens
view
biolog
system
conclus
protein
microarray
technolog
longer
infanc
undoubtedli
serv
invalu
tool
proteom
system
biolog
